EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Opiate stimulation of prolactin secretion is reversed by ovarian hormone treatment



Opiate stimulation of prolactin secretion is reversed by ovarian hormone treatment



Neuroendocrinology 56(2): 195-203



Previous studies have indicated that during the estradiol- and progesterone (P4)-induced surge in luteinizing hormone (LH), the effects of opiates on behavioral, autonomic and neuroendocrine functions are altered. In the present study, we further evaluated the apparent universality of alterations in opiate-mediated function during the LH surge by investigating the effects of morphine sulfate (MS) on prolactin (PRL) secretion during both the estradiol benzoate (EB) and the EB + P4-induced LH surges. All doses of MS tested (0.5, 2.0 and 5.0 mg/kg) resulted in significant increases in PRL secretion in nonestrogen-treated animals which did not show LH/PRL surges. During the LH/PRL surge induced by EB/P4 treatment, MS caused no change in the PRL secretion, while in EB/oil treated animals, a paradoxical and dose-dependent decrease in PRL secretion was observed. The suppression of PRL was 52, 68 and 80% of baseline respectively for the 3 doses of MS. Evaluation of the time dependence of MS on PRL secretion showed that the paradoxical suppression in EB/oil-treated animals was seen only during the LH/PRL surge, occurring at 17.30 h (7.5 h post P4 injection), and not before (12.30 h) or after (23.00 h) the steroid-induced LH/PRL surge. Finally, we assessed the role of pituitary dopamine receptors on the phenomenon of MS-induced PRL suppression in EB/oil rats. Domperidone (1mg/kg), a peripherally active D2 receptor antagonist, administered prior to the morphine challenge, attenuated the opiate-induced PRL suppression in EB/oil-treated animals suggesting that a dopaminergic mechanism is involved in this paradoxical response to morphine.

(PDF emailed within 1 workday: $29.90)

Accession: 002176697

Download citation: RISBibTeXText

PMID: 1407373



Related references

Opiate suppression of luteinizing hormone secretion involves central binding sites different from those mediating opiate effects on prolactin secretion. Acta Endocrinologica Supplementum 108(267): 13-14, 1985

Evaluation of the effects induced by four opiate drugs with different affinities to opioid receptor subtypes on anterior pituitary luteinizing hormone tsh prolactin and growth hormone secretion and on cortisol secretion in normal men. Biomedicine & Pharmacotherapy 40(5): 178-182, 1986

Hormonal changes induced by a partial opiate antagonist nalorphine evaluation of prolactin growth hormone tsh luteinizing hormone fsh and cortisol secretion. European Journal of Clinical Pharmacology 21(1): 23-26, 1981

Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion. Endocrinology 117(3): 1096-1099, 1985

Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion. Journal of Endocrinology 114(3): 469-476, 1987

Mainly micro -opiate receptors are involved in luteinizing hormone and prolactin secretion. Endocrinology 117(3): 1096-1099, 1985

Interaction of the hypothalamic noradrenergic and opiate systems on luteinizing hormone and prolactin secretion. Society for Neuroscience Abstracts 10(2): 928, 1984

Humoral endorphin a new endogenous opiate and its effect on growth hormone and prolactin secretion in the rat. Israel Journal of Medical Sciences 16(12): 878, 1980

Ovarian progestin secretion in lactating rats effect of intra bursal injection of prolactin anti serum prolactin and luteinizing hormone. Endocrinology 94(3): 829-834, 1974

Multiple opiate receptors mu type modulates the neuroendocrine control of luteinizing hormone and prolactin secretion in the rat. Journal of Neurochemistry 44(SUPPL): S87, 1985

Changes in follicle stimulating hormone luteinizing hormone and prolactin secretion and ovarian follicular development during lactation in the rat. Endocrinologia Japonica 28(2): 187-196, 1981

Changes in luteinizing hormone and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion. Life Sciences 37(11): 993-1000, 1985

Secretion of growth hormone, prolactin, ACTH and testosterone after blockade of opiate receptors during stress in humans and rats. Bratislavske Lekarske Listy 86(1): 3-13, 1986

Relationships between luteinizing hormone, follicle-stimulating hormone and prolactin secretion and ovarian follicular development in the weaned sow. Biology of Reproduction 36(1): 175-191, 1987

Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. British Journal of Surgery 71(11): 870-873, 1984